3
|
Fedorov A, Longabaugh WJR, Pot D, Clunie DA, Pieper SD, Gibbs DL, Bridge C, Herrmann MD, Homeyer A, Lewis R, Aerts HJWL, Krishnaswamy D, Thiriveedhi VK, Ciausu C, Schacherer DP, Bontempi D, Pihl T, Wagner U, Farahani K, Kim E, Kikinis R. National Cancer Institute Imaging Data Commons: Toward Transparency, Reproducibility, and Scalability in Imaging Artificial Intelligence. Radiographics 2023; 43:e230180. [PMID: 37999984 PMCID: PMC10716669 DOI: 10.1148/rg.230180] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2023] [Revised: 08/10/2023] [Accepted: 09/12/2023] [Indexed: 11/26/2023]
Abstract
The remarkable advances of artificial intelligence (AI) technology are revolutionizing established approaches to the acquisition, interpretation, and analysis of biomedical imaging data. Development, validation, and continuous refinement of AI tools requires easy access to large high-quality annotated datasets, which are both representative and diverse. The National Cancer Institute (NCI) Imaging Data Commons (IDC) hosts large and diverse publicly available cancer image data collections. By harmonizing all data based on industry standards and colocalizing it with analysis and exploration resources, the IDC aims to facilitate the development, validation, and clinical translation of AI tools and address the well-documented challenges of establishing reproducible and transparent AI processing pipelines. Balanced use of established commercial products with open-source solutions, interconnected by standard interfaces, provides value and performance, while preserving sufficient agility to address the evolving needs of the research community. Emphasis on the development of tools, use cases to demonstrate the utility of uniform data representation, and cloud-based analysis aim to ease adoption and help define best practices. Integration with other data in the broader NCI Cancer Research Data Commons infrastructure opens opportunities for multiomics studies incorporating imaging data to further empower the research community to accelerate breakthroughs in cancer detection, diagnosis, and treatment. Published under a CC BY 4.0 license.
Collapse
Affiliation(s)
- Andrey Fedorov
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - William J. R. Longabaugh
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - David Pot
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - David A. Clunie
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - Steven D. Pieper
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - David L. Gibbs
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - Christopher Bridge
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - Markus D. Herrmann
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - André Homeyer
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - Rob Lewis
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - Hugo J. W. L. Aerts
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - Deepa Krishnaswamy
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - Vamsi Krishna Thiriveedhi
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - Cosmin Ciausu
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - Daniela P. Schacherer
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - Dennis Bontempi
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - Todd Pihl
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - Ulrike Wagner
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - Keyvan Farahani
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - Erika Kim
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| | - Ron Kikinis
- From the Department of Radiology, Brigham and Women’s Hospital
and Harvard Medical School, 399 Revolution Dr, Somerville, MA 02145 (A.F., D.K.,
V.K.T., C.C., R.K.); Institute for Systems Biology, Seattle, Wash (W.J.R.L.,
D.L.G.); General Dynamics Information Technology, Rockville, Md (D.P.); PixelMed
Publishing, Bangor, Pa (D.A.C.); Isomics, Cambridge, Mass (S.D.P.); Departments
of Radiology (C.B.) and Pathology (M.D.H.), Massachusetts General Hospital and
Harvard Medical School, Boston, Mass; Fraunhofer MEVIS, Bremen, Germany (A.H.,
D.P.S.); Radical Imaging, Boston, Mass (R.L.); Artificial Intelligence in
Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Mass
(H.J.W.L.A., D.B.); Radiology and Nuclear Medicine, CARIM & GROW,
Maastricht University, Maastricht, the Netherlands (H.J.W.L.A., D.B.); Frederick
National Laboratory for Cancer Research, Rockville, Md (T.P., U.W.); and
National Cancer Institute, Bethesda, Md (K.F., E.K.)
| |
Collapse
|